Members of Kibbutz Hanita near Israel’s northern border are demanding $11 million from Ballet Vision, the Chinese fund that controls 80% of the Hanita Lenses plant, accusing it of refusing to exercise an option to purchase the kibbutz’s remaining shares, according to a lawsuit filed in Tel Aviv District Court.

In a response letter attached to the lawsuit, the Chinese fund said that since the outbreak of the war in Israel, Beijing has classified Israel as a “high-risk area” and imposed a ban on any new Chinese investments in the country, making it impossible to carry out the option.

According to the lawsuit, in 2021 the kibbutz sold 74% of Hanita Lenses, which manufactures intraocular lenses for medical use, to Ballet Vision for $35 million. Of that sum, $25 million was paid to kibbutz members, with an additional $10 million injected into the company.